# Medtronic Reveal LINQ™ In-Office 2 (RIO 2) Study United States

> **NCT02395536** · NA · COMPLETED · sponsor: **Medtronic Cardiac Rhythm and Heart Failure** · enrollment: 525 (actual)

## Conditions studied

- Arrhythmia

## Interventions

- **OTHER:** office setting
- **OTHER:** hosptial setting

## Key facts

- **NCT ID:** NCT02395536
- **Lead sponsor:** Medtronic Cardiac Rhythm and Heart Failure
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-03-30
- **Primary completion:** 2016-05-31
- **Final completion:** 2016-05-31
- **Target enrollment:** 525 (ACTUAL)
- **Last updated:** 2017-10-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02395536

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02395536, "Medtronic Reveal LINQ™ In-Office 2 (RIO 2) Study United States". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02395536. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*